Clinical Trial Update: Octreotide in the Prevention of Postoperative Complications After Pancreaticoduodenectomy [NA]

View source ↗

Summary

A completed Mansoura University trial evaluating octreotide to prevent postoperative complications after pancreaticoduodenectomy in patients with resectable per…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Periampullary Carcinoma

Drugs mentioned

• Sandostatin (Octreotide acetate)

Snippet

Sponsor: Mansoura University | Conditions: Periampullary Carcinoma Resectable | NA | Status: COMPLETED